23 March 2020

This consultation closes on 4 May 2020

Invitation to comment

The Department of Health is seeking comments from interested parties on the options proposed for the commercial importation of kava into Australia. Comment is particularly sought to understand the risks and benefits of commercial kava importation to the Australian community.

The commercial importation of kava into Australia is phase two of the kava pilot program (pilot) announced by the Prime Minister, the Hon Scott Morrison MP, on 11 October 2019.

Phase one of the pilot which allows incoming passengers to bring in four kilograms of kava for personal use was implemented on 17 December 2020.

Consultation documents

Timetable

Document released for consultation on Monday, 23 March 2020.

Interested parties should respond by close of business Monday 4 May 2020.

Feedback will be released following consideration of submissions (see 'What will happen')

About the consultation

On 11 October 2019, the Prime Minister announced that the Australian Government is stepping up its commitment to the Pacific by launching the kava pilot program which allows for the commercial importation of kava into Australia.

This consultation paper has been prepared to enable interested parties to provide feedback on phase two of the pilot which allows for the commercial importation of kava into Australia.

Content of submissions

Submissions may address any, or all, of the questions asked in the consultation paper.

How to submit

The three options to submit your submission are:

  1. Complete the online consultation submission form to upload your submission in either pdf or word format. Consultation submission form
  2. Complete the consultation submission coversheet and attach to an email with your submission, in either pdf or word format, and email to dcs@health.gov.au with the title KAVA-Submission.
  3. Provide a hardcopy submission with a printed coversheet which may be mailed to:

    Office of Drug Control
    Department of Health
    GPO Box 9848
    Canberra ACT 2601

Print version: Consultation submission cover sheet - DOCX 85KB

Enquiries

Any questions relating to submissions should be directed to the Department of Health by email to dcs@health.gov.au.

What will happen

All submissions will be placed on this website unless marked confidential or indicated otherwise in the submission form (see Privacy information).

The feedback on the consultation paper will be used to inform decisions on the design of phase 2 of the pilot which allow the commercial importation of kava into Australia.

Privacy information

The Department of Health collects your personal information in this submission in order to:

  • contact you if the Department wants to seek clarification of issues raised in your submission or to check whether you consent to certain information that you have provided being made publicly available
  • help provide context about your submission (e.g. to determine whether you are an individual or a director of a company or representing an interest group)
  • seek feedback about how the consultation was undertaken.

Please do not include personal information about other individuals in the body of your submission. Personal information in this context means information or an opinion about an individual whose identity is apparent, or can reasonably be ascertained, from the information or opinion.

More information on privacy can be found on our website.